VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HITHealth In Tech, Inc.
$1.04$56M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksHITEarnings History

HIT logoHealth In Tech, Inc. (HIT) Earnings History

Net Loss

4 years of earnings data (2022–2025) · Currently unprofitable on a TTM basis

TTM Net Income
-$808,031
● Net Loss
TTM EPS (Diluted)
$-0.01
Per share, diluted
YoY EPS Growth
+62.6%
Excellent
Net Margin
3.8%
After-tax profitability
EPS Growth Rate (CAGR)
1Y+62.6%
3Y+137.1%
5YN/A
10YN/A
Operating Margin4.6%
Gross Margin62.8%
Return on Equity8.4%
Return on Assets6.6%
Record Annual Net Income$2MFY2023
Record Quarterly EPS$0.02Q4 2023
Consecutive Profitable Years4years
Q1 2026
Net Income-$2M
EPS (Diluted)$-0.03
YoY Growth+62.6%Excellent
QoQ Growth-425.0%Declining

Loading earnings history...

Health In Tech, Inc. (HIT) Earnings Overview

As of June 28, 2026, Health In Tech, Inc. (HIT) reported trailing twelve-month net income of -$808,031, reflecting +62.6% year-over-year growth. The company earned $-0.01 per diluted share over the past four quarters, with a net profit margin of 3.8%.

Looking at the long-term picture, HIT's historical earnings data spans multiple years. The company achieved its highest annual net income of $2M in fiscal 2023.

Health In Tech, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including HIMS (-$13M net income, 5.5% margin), GDRX ($29M net income, 3.8% margin), EVLV (-$36M net income, -22.7% margin), HIT has room to improve margins relative to the peer group. Compare HIT vs HIMS →

HIT Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
HIT logoHITCurrent
$-808,031$-0.013.8%8.4%+62.6%—
HIMS logoHIMS
-$13M$-0.065.5%25.2%-3.8%
GDRX logoGDRX
$29M$0.093.8%4.5%+104.1%
EVLV logoEVLV
-$36M$-0.21-22.7%-28.0%+41.2%
OSCR logoOSCR
-$39M$-0.12-3.8%-44.4%-1865.9%
CLVT logoCLVT
-$137M$-0.21-8.2%-4.0%+68.8%
Best in group
Lowest in group

HIT Historical Earnings Data (2022–2025)

4 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025$1M+90.7%$2M$0.023.8%4.6%
2024$670,477-72.9%$989,904$0.013.4%5.1%
2023$2M+3005.8%$3M$0.0512.9%17.7%
2022$79,742-$205,582$0.001.4%3.6%

Download Data

Export HIT earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

4+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

HIT — Frequently Asked Questions

Quick answers to the most common questions about buying HIT stock.

What is HIT earnings per share (EPS)?

HIT trailing twelve-month (TTM) diluted EPS is $-0.01, reflecting +62.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2022 to 2025 is available in the table on this page.

What is Health In Tech, Inc.'s net income?

Health In Tech, Inc. (HIT) trailing twelve-month net income is $-808031.00 as of 2025. Earnings grew +62.6% year-over-year. Health In Tech, Inc. has been profitable for 4 consecutive years.

Is HIT profitable?

HIT is not currently profitable on a TTM basis, reporting a net loss of $-808031.00. Net margin is +3.8%. Investors should monitor for a return to profitability.

What is HIT's earnings growth rate?

HIT compound annual EPS growth rates (CAGR): 1-Year: +62.6%, 3-Year: +137.1%, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2022 to 2025.

What are HIT's profit margins?

Health In Tech, Inc. net profit margin is +3.8%, operating margin is +4.6%, and gross margin is +62.8%. Below-average margins reflect competitive or cost pressures. Return on Equity is +8.4%.

Is HIT growing earnings?

Yes, HIT earnings are accelerating — EPS growth of +62.6% exceeds the 5-year CAGR of N/A. TTM net income reached $-808031.00. Earnings momentum is strengthening.

What was HIT's best earnings year?

Health In Tech, Inc.'s highest annual net income on record is $2M, achieved in fiscal year 2023. Earnings history on this page spans 2022 to 2025 and includes all annual and quarterly figures.

What were HIT's earnings last quarter?

HIT's most recent reported quarter was Q1 2026. Net income was $-2M with diluted EPS of $-0.03. For a full breakdown of all quarters, see the quarterly earnings table on this page.

HIT Earnings Over Time (2022–2025)

Net income & EPS — annual and quarterly view